Hildo C. Lantermans

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Dissecting Normal and Abnormal Human Kidney Development Using Multiomics.

Dissecting Normal and Abnormal Human Kidney Development Using Multiomics.

Journal: Journal of the American Society of Nephrology : JASN

Published: November 10, 2025

NNMT inhibition counteracts tubular senescence and fibrosis in early stages of chronic kidney disease.

NNMT inhibition counteracts tubular senescence and fibrosis in early stages of chronic kidney disease.

Journal: Cell reports

Published: April 24, 2025

Presentation of CXCL12γ by heparan sulfate proteoglycans activates CXCR4 without desensitization in normal and malignant B cells.

Presentation of CXCL12γ by heparan sulfate proteoglycans activates CXCR4 without desensitization in normal and malignant B cells.

Journal: Blood advances

Published: July 31, 2024

The dual HCK/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma.

The dual HCK/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma.

Journal: Leukemia

Published: August 03, 2023

The oncogenic human B-cell lymphoma MYD88 L265P mutation genocopies activation by phosphorylation at the Toll/interleukin-1 receptor (TIR) domain.

The oncogenic human B-cell lymphoma MYD88 L265P mutation genocopies activation by phosphorylation at the Toll/interleukin-1 receptor (TIR) domain.

Journal: Blood cancer journal

Published: March 12, 2023

MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas.

MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas.

Journal: Blood cancer journal

Published: January 19, 2023

Correction to: The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma.

Correction to: The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma.

Journal: Journal of hematology & oncology

Published: February 17, 2021

The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma.

The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma.

Journal: Journal of hematology & oncology

Published: September 16, 2020

Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma.

Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma.

Journal: Leukemia

Published: February 25, 2020

Oligonucleotide-directed mutagenesis screen to identify pathogenic Lynch syndrome-associated MSH2 DNA mismatch repair gene variants.

Oligonucleotide-directed mutagenesis screen to identify pathogenic Lynch syndrome-associated MSH2 DNA mismatch repair gene variants.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 09, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026